In October 2007, American Health & Drug Benefits asked Dr. Joseph Antos to discuss the forces that have shaped Medicare's policies and their impact on the various stakeholders in US healthcare. The first part of the interview appeared in AHDB in February 2008. This second part focuses on the impact of the Centers for Medicare & Medicaid Services drug coverage on the future of biologic products. This discussion does not reflect any new developments occurring after October, such as the recent recommendation of the US Food and Drug Administration advisory committee to narrow the indication for erythropoiesis-stimulating agents to patients with cancer.
Joseph Antos is the Wilson H. Taylor Scholar in Health Care and Retirement Policy at AEI. Robert Henry is the editor-in-chief for American Health & Drug Benefits.
On the eve of World Malaria Day, in the latest issue of Health Policy Outlook, Roger Bate traces the failed efforts of the international community to fight malaria since the 1960s--and why they are beginning to work now.
In this provocative new book, Arthur C. Brooks explodes the myths about happiness in America. He examines vast amounts of evidence and empirical research to uncover the truth about who is happy in America, who is not, and why.
Click here to view the entire interview as an Adobe Acrobat PDF
